Author:
Stefanucci Azzurra,Lei Wei,Pieretti Stefano,Novellino Ettore,Dimmito Marilisa Pia,Marzoli Francesca,Streicher John M.,Mollica Adriano
Publisher
Springer Science and Business Media LLC
Reference66 articles.
1. Yekkirala, A. S., Kalyuzhny, A. E. & Portoghese, P. S. Standard opioid agonists activate heteromeric opioid receptors: Evidence for morphine and [d-Ala2-MePhe4-Glyol5]Enkephalin as selective μ-δ agonists. ACS Chem Neurosci. 1, 146–154 (2010).
2. Kramer, T. H., Bartosz-Bechowski, H., Davis, P., Hruby, V. J. & Porreca, F. Extraordinary potency of a novel delta opioid receptor agonist is due in part to increased efficacy. Life Sci. 61, 129–135 (1997).
3. Mosberg, H. I. et al. Bis-penicillamine enkephalins possess highly improved specificity toward 6 opioid receptors. Proc. Natl. Acad. Sci. USA 80, 5871–5874 (1983).
4. Berezowska, I., Chung, N. N., Lemieux, C., Wilkes, B. C. & Schiller, P. W. Dicarba analogues of the cyclic enkephalin peptides H-Tyr-c[D-Cys-Gly-Phe-D(or L)-Cys]NH2 retain high opioid activity. J. Med. Chem. 50, 1414–1417 (2007).
5. Weber, S. J. et al. Assessment of an in vitro blood-brain barrier model using several [Met5]enkephalin opioid analogs. J. Pharmacol. Exp. Ther. 266, 1649–1655 (1993).
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献